Myeloma knows no borders—people everywhere are affected by this complex disease.
Fair Treatment, Access, and Opportunity for All.
The IMF's Diversity, Equity, and Inclusion policy strives to recognize, include, and treat all members of the myeloma community equally. It also defines health disparities and takes a deeper dive into how these disparities affect specific racial and ethnic groups. The IMF believes that all patients deserve equal access to care and treatments.
A Message From Our President & CEO

Diversity
The Myeloma Community is diverse not only in gender, race, ethnicity, sexual orientation, ability, religion, and age, but in cultural backgrounds, life experiences, and ideology. Diversity and inclusion are integral aspects of the myeloma community. We are One Myeloma Nation.
Equity
We are committed to equity and do not tolerate bias, prejudice, harassment, and discrimination. Our vision is to practice fair treatment, access, and equity for all.
Inclusion
We are committed to make every effort to ensure that everyone in our workplace, events, and programs are provided equal access to opportunities and resources. All participants are respectfully heard and supported to feel a sense of belonging and inclusion.

Explore the IMF's M-Power Project. Partnered with cities across the U.S., this project aims to eliminate health disparities and create better and more equitable access to healthcare for all.

with support from:
AbbVie, Amgen, Bristol Myers Squibb, Genentech , GSK, Johnson & Johnson, Karyopharm Therapeutics, Kite, and Sanofi